Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
Clinical trial NCT00663052 · COMPLETED
Trial details
- NCT number
- NCT00663052
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2010-01-01
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.